James Flynn
About James Flynn
James Flynn - Title and Current Roles
James Flynn serves as an Independent Director and is currently the Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in 2021. In addition to his leadership role at Nerium Capital, Flynn serves on the Board of Directors for ARCA Biopharma (NASDAQ: ABIO), MEI Pharma (NASDAQ: MEIP), and Axiom Health (private).
James Flynn - Educational Background
James Flynn holds an S.B. degree in Management Science with a concentration in Finance and a minor in Economic Science from the Massachusetts Institute of Technology (MIT). This educational foundation has provided him with a strong analytical and financial background, aiding his career in investment management and his role as a Chartered Financial Analyst (CFA).
James Flynn - Career at Nerium Capital LLC
In 2021, James Flynn founded Nerium Capital LLC and currently serves as its Managing Member and Portfolio Manager. At Nerium Capital, Flynn applies his extensive experience in investment management to oversee the firm’s portfolio and guide its strategic investments. His role involves making critical investment decisions and managing client relationships.
James Flynn - Experience in Investment and Finance
James Flynn has a diverse career in investment and finance. From 2002 to 2003, he was involved in the credit research/high yield group at Putnam Investments. He then held various roles at Amici Capital, LLC, including healthcare portfolio manager from 2008 to 2017. Flynn further expanded his expertise as a therapeutics analyst at Aptigon Capital (a Citadel Company) from 2017 to 2018 before founding his own investment firm.
James Flynn - Board Memberships
James Flynn serves on the Board of Directors for multiple companies, including ARCA Biopharma (NASDAQ: ABIO), MEI Pharma (NASDAQ: MEIP), and Axiom Health (private). In these roles, he provides strategic guidance and oversight, leveraging his extensive background in finance and management to support the companies' growth and operational objectives.